Exceptional results in neuroendocrine-metastases-caused paraplegia treated with [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC), a radiolabelled somatostatin analogue

Clinical Oncology

Volumn 12, Issue 2, 2000, Pages 121-123

  Waldherr, C ^a   Haldemann, A ^a   Maecke, H R ^a   Crazzolara, A ^a   Mueller Brand, J ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

90Y DOTATOC; Bone metastases; Internal radiotherapy; Neuroendocrine tumour; Paraplegia

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; 1,4,7,10 TETRAAZACYCLODODECANE N,N,N,N TETRAACETIC ACID OCTREOTIDE[1 DEXTRO PHENYLALANINE 3 TYROSINE]; ANGIOPEPTIN; CISPLATIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; OCTREOTIDE; PENTETREOTIDE; SOMATOSTATIN DERIVATIVE; STREPTOZOCIN; UNCLASSIFIED DRUG; YTTRIUM 90;

ADULT; ARTICLE; BONE METASTASIS; CANCER RADIOTHERAPY; CASE REPORT; DRUG EFFICACY; HUMAN; LUNG TUMOR; LYMPHOCYTOPENIA; MALE; NEUROENDOCRINE TUMOR; PARAPLEGIA; PRIORITY JOURNAL; SPINAL CORD COMPRESSION;

EID: 0034019986     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1053/clon.2000.9131     Document Type: Article

References (8)

1. Fuller BG, Heiss J, Oldfield EH. Spinal cord compression. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 5th ed. New York: Lippincott-Raven, 1997:2476-86.
2. Prinz RA, Dorsch TR, Lawrence AM. Clinical aspects of glucagon producing islet cell tumors. Am J Gastroenterol 1981;76:125-31.
3. Oeberg K. Advances in chemotherapy and biotherapy of endocrine tumors. Curr Opin Oncol 1998;10:58-65.
4. Faiss S, Scherubl H, Riecken EO, et al. Drug therapy in metastatic neuro-endocrine tumors of the gastroenteropancreatic system. Recent Results Cancer Res 1996; 142:193-207.
5. Pelley RJ, Bukowski RM. Recent advances in systemic therapy for gastrointestinal neuroendocrine tumors. Curr Opin Oncol 1999;11:32-7.
6. British Association of Surgical Oncology Guidelines. The management of metastatic bone disease in the United Kingdom. Eur J Surg Oncol 1999;25:3-23.
7. Otte A, Mueller-Brand J, Dellas S, et al. Yttrium-90 labelled somatostatin-analogue for cancer treatment. Lancet 1998;351:417-8.
8. 90Y-DOTATOC. Eur J Nucl Med 1999;26:877-86.